Cleared Traditional

K022041 - LYPHOCHEK WHOLE BLOOD CONTROL

K022041 is the FDA 510(k) clearance for LYPHOCHEK WHOLE BLOOD CONTROL by Bio-Rad Laboratories, Inc.. It is a Class 1 Immunology device (product code JJY) cleared through the Traditional 510(k) pathway after a 22-day FDA review.

K022041 · Bio-Rad Laboratories, Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2002
Decision
22d
Days
Class 1
Risk

K022041 is an FDA 510(k) clearance for the LYPHOCHEK WHOLE BLOOD CONTROL, MODELS 561, 562, 563. Classified as Multi-analyte Controls, All Kinds (assayed) (product code JJY), Class I - General Controls.

Submitted by Bio-Rad Laboratories, Inc. (Irvine, US). The FDA issued a Cleared decision on July 16, 2002 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 862.1660 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Bio-Rad Laboratories, Inc. devices

Submission Details

510(k) Number K022041 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 24, 2002
Decision Date July 16, 2002
Days to Decision 22 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
82d faster than avg
Panel avg: 104d · This submission: 22d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code JJY Multi-analyte Controls, All Kinds (assayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJY Multi-analyte Controls, All Kinds (assayed)

All 342
Devices cleared under the same product code (JJY) and FDA review panel - the closest regulatory comparables to K022041.
PH AND AMINES EXTERNAL CONTROL SET
K022851 · Quidel Corp. · Sep 2002
LIQUICHEK IMMUNOLOGY CONTROL LEVEL 1, 2, AND 3-1 ML, MODEL 591, 592, 593
K022991 · Bio-Rad · Sep 2002
RANDOX LIPID CONTROL
K022591 · Randox Laboratories, Ltd. · Aug 2002
MEDICA EASYQC BLOOD GAS/ELECTROLYTE CONTROL
K021930 · Bionostics, Inc. · Jun 2002
MODIFICATION TO N/T RHEUMATOLOGY CONTROLS SL 1 & 2
K021381 · Dade Behring, Inc. · Jun 2002
LIQUICHEK URINE CHEMISTRY CONTROL
K020817 · Bio-Rad Laboratories, Inc. · Apr 2002